On November 20, Haryana Health Minister Anil Vij was administered a trial dose of Covaxin, the potential COVID-19 vaccine from drug maker Bharat Biotech. On Saturday, the minister said he had tested positive for COVID-19. However, since the trials are “double-blinded and randomized”, it is unclear whether the minister received the trial vaccine or the placebo. Health experts and journalists have cautioned against dismissing the efficacy of the vaccine.

On November 20, Vij was the first in Haryana to participate in Covaxin’s trials. Besides Vij, over 400 persons from Haryana, including Rohtak PGIMS’ Vice Chancellor Dr. OP Kalra, too participated in the third phase human trials and took the vaccine shot.

Anil Vij had been administered a trial dose of Bharat Biotech’s #Covaxin on November 20. He became one of 26,000 volunteers for the third phase of human trials of the vaccine candidate.

Health department officials said Vij was under close surveillance by a team of doctors, and his health parameters were fine.

A team of Rohtak Post Graduate Institute of Medical Sciences had administered the vaccine to Vij at Ambala Cantonment’s civil hospital. His health and vitals were being monitored on a weekly basis, ever since.

On Friday, a three-member delegation from the Jannayak Janata Party (JJP), led by the party’s state chief Nishan Singh, Dushyant Chautala’s younger brother Digvijay Chautala and another JJP leader Randhir Singh, had met Vij at his office.

After getting Covaxin’s trial shot for Covid-19Vij had said: “It is a matter of pride for every Indian that Bharat Biotech is coming up with an indigenous vaccine for Covid-19. I had volunteered to become one of the participant for the third phase so that people shed their fears and come forward to volunteer.”

Hours after Haryana Health Minister Anil Vij, who was administered a dose of Covaxin last month, tested positive for Covid-19, Hyderabad-based Bharat Biotech said that the efficacy of its Covid-19 vaccine could be determined only fourteen days after a second dose.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here